- "Covid-19 and ivermectin: many trials, few results, no proven efficacy " (13 February 2021) > HERE
- "The ChAdOx1 nCoV-19 covid-19 vaccine from AstraZeneca: great uncertainty over its efficacy" (29 January 2021) > HERE
- "The covid-19 messenger RNA vaccine from Moderna: as with the tozinameran vaccine (Comirnaty°, Pfizer/BioNTech), limited data and unanswered questions" (6 January 2021) > HERE
- "The covid-19 messenger RNA vaccine tozinameran (Comirnaty°, from Pfizer and BioNTech) in elderly patients: limited data, many uncertainties" (23 December 2020) > HERE
- "Covid-19 and vitamin D: too uncertain" (15 December 2020) > HERE
- "Evaluation of covid-19 vaccines: the questions to ask" (20 November 2020) > HERE
- "Covid-19 patients who are not hospitalised: anticoagulation is rarely justified" (24 September 2020) > HERE
- "Proton pump inhibitors: increased risk of severe covid-19" (15 September 2020) > HERE
- "Hydroxychloroquine in covid-19: no proven efficacy, including in less severe forms of the disease" (24 July 2020) > HERE
- "Covid-19: remdesivir (Veklury°) authorised in the European Union, yet much remains unknown or uncertain" (13 July 2020) > HERE
- "Covid-19 and severe breathing problems: dexamethasone reduced mortality in one trial" (24 June 2020) > HERE
- "Lack of access to drug evaluation data: a recurrent problem, not confined to covid-19" (8 June 2020) > HERE
- "Covid-19 and hydroxychloroquine (Plaquenil°): new data show no evidence of efficacy" (16 April 2020) > HERE
- "New data on the cardiac adverse effects of the combination of hydroxychloroquine (Plaquenil°) with azithromycin (Zithromax° or other brands)" (16 April 2020) > HERE
- "Covid-19 and hydroxychloroquine (Plaquenil°): still no conclusive results" (15 April 2020) > HERE
- "Covid-19 and hydroxychloroquine: uncertainties and unanswered questions" (2 April 2020) > HERE
- "Covid-19 and hydroxychloroquine: caution" (30 March 2020) > HERE
- "Covid-19 and drug trials: what to make of the initial results?" (23 March 2020) > HERE
- For more information in French, see www.prescrire.org > Dans l'actualité
©Prescrire February 2021
For more updates, follow us on Facebook and Twitter

Enjoy full access to Prescrire International, and support independent information
|